Now that Mynosys Cellular Devices has received FDA 510(k) clearance for its Zepto Capsulotomy System for cataract surgery, the company is planning its US launch August 1 and has partnered with Precision Lens of Bloomington, MN, to distribute the platform, Mynosys CEO John Hendrick tells OIS Weekly. Mynosys is based in Fremont, CA.

Click Here to Read More from